XML 28 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities:      
Net earnings $ 40,005 $ 38,765 $ 33,277
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 9,641 9,291 8,559
Stock compensation expense 3,906 3,692 3,992
Shares issued under employee benefit plans 310 475 431
Deferred income tax expense (92) 307 (669)
Provision for (recovery of) doubtful accounts 57 (27) (225)
Foreign currency transaction loss (gain) 88 197 (25)
Gain on sale of a product line 0 0 (931)
Loss on impairment of assets 0 94 311
Changes in assets and liabilities      
Accounts receivable (7,642) (2,697) (2,744)
Inventories (1,979) (3,009) (1,863)
Prepaid expenses and other current assets (387) (339) 43
Accounts payable and accrued expenses 5,775 739 2,645
Income taxes 3,890 (2,924) (4,091)
Other 209 338 320
Net cash provided by operating activities 53,781 44,902 39,030
Cash flows from investing activities:      
Proceeds from sale of a product line 0 0 1,125
Acquisition of a business 0 0 (4,661)
Capital expenditures (13,883) (6,612) (7,557)
Proceeds from sale of property, plant and equipment 0 28 0
Intangible assets (acquired) disposed (121) (25) 44
Net cash used in investing activities (14,004) (6,609) (11,049)
Cash flows from financing activities:      
Proceeds from long-term debt 178 0 97
Principal payments on long-term debt (1,386) (3,557) (1,458)
Proceeds from stock options exercised and restricted shares purchased 1,905 4,451 4,343
Excess tax benefits from stock compensation 2,862 2,894 4,230
Dividends paid (11,703) (4,311) (3,091)
Purchase of treasury stock (1,699) (109) (937)
Net cash (used in) provided by financing activities (9,843) (632) 3,184
Effect of exchange rate changes on cash 22 (133) (344)
Increase in cash and cash equivalents 29,956 37,528 30,821
Cash and cash equivalents beginning of period 114,781 77,253 46,432
Cash and cash equivalents end of period $ 144,737 $ 114,781 $ 77,253